CrushSCI.com
提供学术论文选刊润色服务
Experimental Hematology & Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Experimental Hematology & Oncology

Springer SCIE OA
2026新锐 1区2025中科院 2区2025 JCR Q1
136.2平均天数
131.5中位天数
61最短天数
235最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

68 天

Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma

作者Callee Brooks; Leslie Mader; Kathryn Kennedy; Phyu Thin Naing; Salyka Sengsayadeth; Bhagirathbhai Dholaria; Adetola Kassim; Sarah Profitt; Muhamed Baljevic

作者单位1. Department of Pharmacy, Vanderbilt University Medical Center, Nashville, USA; 2. Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA; 3. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA

PDF源文件 DOI 网页
117 天

Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series

作者Yanling Ren; Wei Lang; Yu Xu; Chen Mei; Xianbo Huang; Shasha Wang; Jiejing Qian; Hongyan Tong

作者单位1. Department of Hematology, The First Affiliated Hospital, school of Medicine, Zhejiang University, Hangzhou, China

PDF源文件 DOI 网页
163 天

AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models

作者Xiaoting Zhang; Congcong Cao; Zeqi Huang; Dongde Wu; Tao Yin; Yuchen Liu; Jian Shen; Aolin Li; Shuofei Yang; Lei Nie

作者单位1. Central Laboratory, Shenzhen Bao’an District Songgang People’s Hospital, Shenzhen, China; 2. Shenzhen Bao’an medical college of Guangdong Pharmaceutical University, Shenzhen, China; 3. Hubei Shizhen Laboratory, School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China; 4. Shenzhen Institute of Translational Medicine, Shenzhen Second People’s Hospital, Health Science Center, The First Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen, China; 5. Department of Hepatobiliary and Pancreatic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 6. Department of Urology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China; 7. Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

PDF源文件 DOI 网页
202 天

Cellular adhesion-dependent 3D morphogenesis indicating brain tumor aggressiveness and chemosensitivity in spherical cavity culture

作者Thuy Huynh; Jieun Kim; Sarnai Amartumur; Inhee Choi; Ji Yeoun Lee; Luke P. Lee; Chaejeong Heo

作者单位1. Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University, Suwon, Republic of Korea; 2. Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, Republic of Korea; 3. Department of Life Science, Department of Chemistry, University of Seoul, Seoul, Republic of Korea; 4. Division of Pediatric Neurosurgery, Seoul National University Children’s Hospital, Seoul, Republic of Korea; 5. Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, USA; 6. Korea Biomedical Institute for Global Health Research and Technology (K-BIGHEART), Pohang University of Science and Technology (POSTECH), Gyeongbuk, Republic of Korea

PDF源文件 DOI 网页
151 天

The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity

作者Edoardo Peroni; Rosario Amato; Martina Bado; Mosè Favarato; Antonio Rosato

作者单位1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. UOC Genetica Medica, Azienda Ospedaliera Universitaria Dulbecco, Università Magna Graecia, Catanzaro, Italy; 3. Lab. Immuno-Genetica, Dpt. Scienze della Salute, Università degli Studi “Magna Graecia” di Catanzaro, Catanzaro, Italy; 4. Dipartimento di Direzione Medica del Presidio Ospedaliero di Mestre, UOSD Genetica e Citogenetica, Venice, Italy; 5. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy

PDF源文件 DOI 网页
62 天

Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting

作者Tiantian Zhang; Heng Jiang; Delong Liu

作者单位1. Department of Internal Medicine, University of Central Florida, Pensacola, USA; 2. Chinese American Hematologist and Oncologist Network (CAHON), Milwaukee, USA; 3. Division of Hematology and Oncology, Department of Internal Medicine, Westchester Medical Center/New York Medical College, Valhalla, USA

PDF源文件 DOI 网页
146 天

Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs

作者Edoardo Peroni; Marco Pizzi; Marco Basso; Alessandro Atanasio; Elisabetta Calistri; Michele Gottardi; Antonio Rosato

作者单位1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. Department of Medicine-DIMED, Surgical Pathology and Cytopathology Unit, Padua University Hospital, Padua, Italy; 3. Pharmacy, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; 4. Onco-Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy; 5. Department of Surgery Oncology and Gastroenterology, University of Padova, Padova, Italy

PDF源文件 DOI 网页
67 天

Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK + ALCL

作者Guiming Li; Jun Wang; Shiguang Ye; Lixin Zhou; Yanli Sun; Bowen Li; Yunshuo Zhao; Yi Ding; Yu Zeng; Bin Xue; Guangming Wang; Fangce Wang; Xiu Luo; Aibin Liang; Ellen L. Weisberg; Wenjun Zhang; Wenchao Lu; Jing Yang

作者单位1. Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China; 2. Lingang Laboratory, Shanghai, China; 3. Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; 4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 5. Department of Medicine, Harvard Medical School, Boston, USA

PDF源文件 DOI 网页
61 天

Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting

作者Haibo Yu; Ting Shi; Hong-Hu Zhu

作者单位1. Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; 2. Chinese Institutes for Medical Research, Beijing, China; 3. Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing, China

PDF源文件 DOI 网页
106 天

Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion

作者Zhiru Gao; Linlin Yang; Linlin Wang

作者单位1. Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。